|
ST Elevation MI: General |
ACC/AHA STEMI Guidelines: American College of Cardiology/American Heart Association
-For the Management of Patients with STEMI - Focus Emergency Care
Acute Myocaridal Infarction (AMI) Epidemiology
COMMIT/CCS-2: Clopidogrel and Metoprolol in Myocardial Infarction Trial
-Commentary on the 46,000 Patients Randomized to Lopressor in STEMI by Dr. Christopher Cannon (ACC 2005)
-Commentary on the 46,000 Patients Randomized to Plavix in STEMI by Dr. Christopher Cannon (ACC 2005)
Door to Balloon Times
-And Mortality: Time Dependence of Reperfusion Therapy: "Wavefront" Phenomenon of Necrosis in Dogs by Dr. C. Michael Gibson (2006)
-Regional STEMI Networks in Southern California Reduce Door-to-Balloon Times: Pooled Data from 4 Counties by Dr. Ivan Rokos (TCT 2007)
False Positive ST Elevation
-In Patients Undergoing Direct Percutaneous Coronary Intervention by Dr. David M. Larson
The Mayo Clinic Protocol
-Regional Systems of Care to Optimize Timeliness of Reperfusion Therapy for STEMI by Dr. Henry H. Ting (2007)
NRMI Registry: National Registry of Myocardial Infarction
-Milestones in Acute Myocardial Infarction
-Care of ST-Segment Elevation Patients: Insights from NRMI by Dr. C. Michael Gibson
Phase II Angiographic Trials
-Overview Of Combination Therapy with Full Dose GPIIb/IIIa Inhibition Plus Reduced Dose Fibrinolysis
RACE: Reperfusion in AMI in Carolina Emergency Departments
-Overview by Dr. Christopher Granger
Selection of Patients for Reperfusion Therapy
ST Elevation MI
-Incorporating Patient Risk into Decisions Regarding the Optimal Reperfusion Strategy for ST Elevation MI by Dr. Duane S. Pinto
TIMI Trials 1-17
-Over 80 Slides from the Past 15 Years of TIMI Trials all in One Slide Set
Who Are We? Slide
Downloading Policy
Financial Disclosure
We Do Not
Promote Off Label Product Use
Copyright
Source of Slides
Editorial Policy
Links Policy
Privacy
Policy
Access
CME Programs
© 1999-2009 by
Clinical Trial Results .org. None of the materials on this website may be
reproduced, modified, distributed, transmitted, republished, displayed, or
performed unless prior written approval is obtained by Clinical Trial Results.
All such requests should be forwarded to Susan J. Marble at
smarble@clinicaltrialresults.org. For further information please see the
Policy section.
Webmaster